Compare TTK HEALTHCARE with Wockhardt - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs WOCKHARDT - Comparison Results

WOCKHARDT 
   Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE WOCKHARDT TTK HEALTHCARE/
WOCKHARDT
 
P/E (TTM) x 18.8 -22.2 - View Chart
P/BV x 1.5 1.2 128.4% View Chart
Dividend Yield % 1.0 0.0 31,183.1%  

Financials

 TTK HEALTHCARE   WOCKHARDT
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-19
WOCKHARDT
Mar-18
TTK HEALTHCARE/
WOCKHARDT
5-Yr Chart
Click to enlarge
High Rs1,2151,012 120.1%   
Low Rs610532 114.8%   
Sales per share (Unadj.) Rs444.4355.9 124.9%  
Earnings per share (Unadj.) Rs17.2-60.3 -28.6%  
Cash flow per share (Unadj.) Rs27.6-46.8 -59.1%  
Dividends per share (Unadj.) Rs5.000.01 50,000.0%  
Dividend yield (eoy) %0.50 42,285.4%  
Book value per share (Unadj.) Rs177.9257.8 69.0%  
Shares outstanding (eoy) m14.13110.63 12.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.12.2 94.7%   
Avg P/E ratio x52.9-12.8 -413.3%  
P/CF ratio (eoy) x33.0-16.5 -200.1%  
Price / Book Value ratio x5.13.0 171.3%  
Dividend payout %29.00 -174,747.9%   
Avg Mkt Cap Rs m12,89485,379 15.1%   
No. of employees `0002.36.3 37.0%   
Total wages/salary Rs m1,3079,371 13.9%   
Avg. sales/employee Rs Th2,715.76,295.0 43.1%   
Avg. wages/employee Rs Th565.31,498.3 37.7%   
Avg. net profit/employee Rs Th105.4-1,066.3 -9.9%   
INCOME DATA
Net Sales Rs m6,27939,369 15.9%  
Other income Rs m781,202 6.4%   
Total revenues Rs m6,35640,571 15.7%   
Gross profit Rs m49618 2,708.2%  
Depreciation Rs m1471,495 9.8%   
Interest Rs m342,555 1.3%   
Profit before tax Rs m393-2,830 -13.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-3,582 0.0%   
Tax Rs m149257 57.9%   
Profit after tax Rs m244-6,669 -3.7%  
Gross profit margin %7.90 16,980.8%  
Effective tax rate %37.9-9.1 -417.6%   
Net profit margin %3.9-16.9 -22.9%  
BALANCE SHEET DATA
Current assets Rs m2,71733,796 8.0%   
Current liabilities Rs m1,57126,917 5.8%   
Net working cap to sales %18.317.5 104.5%  
Current ratio x1.71.3 137.8%  
Inventory Days Days3279 40.5%  
Debtors Days Days4789 52.3%  
Net fixed assets Rs m99139,664 2.5%   
Share capital Rs m141553 25.5%   
"Free" reserves Rs m2,37327,968 8.5%   
Net worth Rs m2,51428,522 8.8%   
Long term debt Rs m321,731 0.0%   
Total assets Rs m4,15881,620 5.1%  
Interest coverage x12.6-0.1 -11,733.2%   
Debt to equity ratio x00.8 0.2%  
Sales to assets ratio x1.50.5 313.1%   
Return on assets %6.7-5.0 -132.4%  
Return on equity %9.7-23.4 -41.5%  
Return on capital %16.9-7.7 -220.7%  
Exports to sales %3.60-   
Imports to sales %0.50-   
Exports (fob) Rs m225NA-   
Imports (cif) Rs m31NA-   
Fx inflow Rs m2259,807 2.3%   
Fx outflow Rs m711,789 4.0%   
Net fx Rs m1548,019 1.9%   
CASH FLOW
From Operations Rs m173684 25.3%  
From Investments Rs m976,302 1.5%  
From Financial Activity Rs m-307-7,695 4.0%  
Net Cashflow Rs m-38-664 5.7%  

Share Holding

Indian Promoters % 65.4 74.5 87.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.7 2.3 160.9%  
FIIs % 5.2 7.7 67.5%  
ADR/GDR % 0.0 0.1 -  
Free float % 25.8 15.4 167.5%  
Shareholders   12,723 67,757 18.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   GLENMARK PHARMA  UNICHEM LAB  DR. REDDYS LAB  DIVIS LABORATORIES  ALEMBIC LTD  

Compare TTK HEALTHCARE With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex's Journey From 640 Points Down to 2,000 Points Up(Podcast)

What a week it was! While crude oil prices dragged the Indian stock markets lower, finance minister Nirmala Sitharaman's boosters sent markets soaring and how!

Related Views on News

WOCKHARDT Announces Quarterly Results (1QFY20); Net Profit Up 57.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, WOCKHARDT has posted a net profit of Rs 369 m (up 57.2% YoY). Sales on the other hand came in at Rs 9 bn (down 14.3% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 53.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, TTK HEALTHCARE has posted a net profit of Rs 36 m (down 53.8% YoY). Sales on the other hand came in at Rs 2 bn (up 3.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of TTK HEALTHCARE for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of TTK HEALTHCARE. Also includes updates on the valuation of TTK HEALTHCARE.

TTK HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 38.0% (Quarterly Result Update)

Jun 12, 2019 | Updated on Jun 12, 2019

For the quarter ended March 2019, TTK HEALTHCARE has posted a net profit of Rs 50 m (down 38.0% YoY). Sales on the other hand came in at Rs 1 bn (down 3.8% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

WOCKHARDT Announces Quarterly Results (4QFY19); Net Profit Up 90.8% (Quarterly Result Update)

May 7, 2019 | Updated on May 7, 2019

For the quarter ended March 2019, WOCKHARDT has posted a net profit of Rs 139 m (up 90.8% YoY). Sales on the other hand came in at Rs 10 bn (down 3.8% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

More Views on News

Most Popular

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Rare Opportunity to Buy the Top 5 Stocks in the Market(The 5 Minute Wrapup)

Sep 16, 2019

The stock market today is throwing up a great opportunity to pile on quality stocks.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

This Company Will Do Well Despite the Slowdown(The 5 Minute Wrapup)

Sep 11, 2019

How financial inclusion provides a big runway for this stock recommendation.

The 5 Best Trading Opportunities I've Spotted(Profit Hunter)

Sep 13, 2019

These 10 auto stocks should be in your watchlist for the next 32 months. Paste them on your workstation NOW.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Sep 20, 2019 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE - PIRAMAL ENTERPRISES COMPARISON

COMPARE TTK HEALTHCARE WITH

MARKET STATS